Atrial cardiomyopathy reflects a shared atrial remodeling process that increases the risk of atrial fibrillation, heart failure, and stroke. Findings from the European Heart Journal (EHJ) highlight how AtCM markers enhance cardiovascular risk prediction.

Among 26,467 UK Biobank participants with cardiac magnetic resonance imaging and electrocardiographic data, left atrial dilation, mechanical dysfunction, P-wave prolongation, and abnormal P-wave terminal force were assessed as markers of AtCM. One in seven participants had at least one marker, while 2.3% showed two or more.

Having one marker increased the risk of AF by 88%, and two or more markers were associated with a 4.6-fold higher AF risk. The same group faced approximately threefold higher risks of HF and stroke. Integration of AtCM markers improved AF risk prediction by 13.7% and showed additive effects when combined with clinical and genetic factors.

These results highlight atrial cardiomyopathy as a central mechanism linking AF, HF, and stroke, underscoring the value of early detection and risk-based intervention in cardiovascular care.